Nuvalent

2 followers

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectiv... Read more

Employees

11-50

Links


Org chart

Collapse
Matthew Metivier
VP, Human Resources
Jessie Lin
Senior Vice President, Corporate Strategy & Portfolio Management
Elizabeth Correia - Candido
Manager, Medical Affairs Operations
Jeffrey Lee
Vice President, IT
Jason Waters
Senior Vice President, Head of Commercial
Christopher Turner
Chief Medical Officer
Alex Balcom
Chief Financial Officer
Benjamin Lane
SVP, Technical Operations
Darlene Noci
Chief Development Officer
Henry Pelish
Chief Scientific Officer

Board & advisors

Matthew D. Shair
Founder & Head Scientific Advisor
Gary Gilliland
Independent Director
D. Ross Camidge
Scientific Advisor
Michael Meyers
Independent Board Member
Pasi Jänne
Scientific Advisor
Aaron Hata
Scientific Advisor
Nancy Kohl
Scientific Advisor
Alexander Drilon
Scientific Advisor
Sapna Srivastava
Independent Board Member